Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,563.2
19.1 (0.75%)

 

  • STI Straits Times Index
    2,563.2
    19.1 (0.75%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,556.6
    -8.1 (-0.52%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,244.0
    353.3 (1.42%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,319.3
    -21.0 (-0.63%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,844.0
    93.7 (0.41%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,233.5
    43.3 (0.83%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,319.8M
  • Value: 1,597.5M
  • Rise: 152
  • Fall: 164
  • Unch: 491

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl1.410+0.435
Genting Sing0.705+0.030
ThaiBev0.600-0.005
Vicplas Intl0.375-0.030
Oceanus^0.008-
Matex Intl0.034+0.003
Singtel2.380+0.020
Rex Intl0.182-0.001
ISDN0.390-0.010
Frasers L&C Tr1.270-0.050

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NANOVIRICIDES INC NANOVIRICIDES INC
Updated on 11 Aug 2020 (End of trading day)
Last (USD): 6.040 Change: -0.250 High: 6.300 Remarks: -
Change (%): -3.97 Low: 5.910
Open 6.300 Yesterday's Close 6.29
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 385,647 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13357 Trailing EPS (USD) e -0.21855 NAV (USD) b 0.2270
PE a - Trailing PE f - Price / NAV b 26.6079
Dividend (USD) d - Cash In Hand (USD) g 0.0968 Issued & Paid-up Shares c 10,655,200
Dividend Yield (%) d - Price / Cash In Hand g 62.397 Treasury Shares h -
Market Cap (M) 380.955 Enterprise Value (M) 376.030
Piotroski F Score 1 Exchange Code NNVC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 195.79 Free Float (%) 89.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NANOVIRICIDES INC NYSE American 380.955 - - 26.6079 -
Industry Biotechnology NYSE American 135.484 - - 3.9328 -
Local Peer IBIO INC NYSE American 256.180 - - 64.6370 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 301.014 - - 59.4521 -
Local Peer PFENEX INC NYSE American 301.877 285.301 - 4.0853 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 135.268 - - 1.3603 -
Local Peer CEL-SCI CORP NYSE American 109.138 - - 8.9394 -
Local Peer AIM IMMUNOTECH INC NYSE American 90.369 - - 2.6313 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 86.410 2.416 2.329 0.9968 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 78.636 - - 1.0678 -
Local Peer 22ND CENTURY GROUP INC NYSE American 73.062 - - 1.3564 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 75.871 - - -10.2353 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 62.833 - - 1.8766 -
Local Peer ORAGENICS INC NYSE American 45.332 - - 7.9038 -
Other Local Peers ACTINIUM PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 137,433.097 17.525 18.829 12.8936 2.496
Global Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Global Peer GILEAD SCIENCES INC NASDAQ 85,378.332 15.852 - 4.7361 3.737
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 68,205.889 57.958 32.779 9.0708 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 63,713.895 30.113 21.355 7.0345 -
Global Peer ILLUMINA INC NASDAQ 49,816.660 49.717 71.886 10.9175 -
Global Peer BIOGEN INC NASDAQ 45,901.271 7.795 7.745 4.0589 -
Global Peer WUXI BIO HKEx 209,381.208 182.139 182.139 14.6415 -
Global Peer MODERNA INC NASDAQ 27,214.665 - - 9.2350 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), ALEXION PHARMACEUTICAL INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), Lonza (SGX), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GENSCRIPT BIO (HKEx), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), 3SBIO (HKEx), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ALLOVIR INC (NASDAQ), HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), TG THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), ALPHAMAB-B (HKEx), VAXCYTE INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), LUMINEX CORP(DEL) (NASDAQ), MYOVANT SCIENCES LTD (NYSE), CYTOKINETICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CORTEXYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), ALECTOR INC (NASDAQ), ARVINAS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), VAXART INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KINTOR PHARMA-B (HKEx), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KADMON HLDGS INC (NYSE), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), AKOUOS INC (NASDAQ), AGENUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVROBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DPHARMA (Bursa), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ARDELYX INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), LIMINAL BIOSCIENCES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), KAMADA (NASDAQ), ESSEX BIO-TECH (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), CABALETTA BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AFFIMED N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), MEDICINOVA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VERASTEM INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), XOMA CORP (NASDAQ), IMUGENE LIMITED (ASX), EQUILLIUM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CIDARA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OTONOMY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), INMUNE BIO INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CAPRICOR THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), SAVARA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VACCINEX INC (NASDAQ), UNI-BIO GROUP (HKEx), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), OCUGEN INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SYNLOGIC INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANTEOTECH LIMITED (ASX), 9 METERS BIOPHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), IMMUTEP LTD (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PRECIPIO INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CT ENTERPRISE (HKEx), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), BIONOMICS LTD (ASX), AETERNA ZENTARIS INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOSINO BIO-TEC (HKEx), ADITX THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), Suntar Eco-City (SGX), REGENEUS LTD (ASX), ITERUM THERAPEUTICS PLC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), RHINOMED LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), PATRYS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), LEAF RESOURCES LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN H-NEW (HKEx), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.250
-3.97 %
10 Days --0.520
-7.93 %
20 Days --0.870
-12.59 %
Medium Term Return 3 Months --4.500
-42.69 %
6 Months --1.100
-15.41 %
1 Year -+1.040
+20.80 %
Long Term Return 2 Years --0.760
-11.18 %
3 Years --20.160
-76.95 %
5 Years --19.760
-76.59 %
Annualised Return Annualised --
-25.20 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.271 - 19.200 Change From 1 Year Low +4.769 % Change From 1 Year Low (%) +375.10
Change From 1 Year High -13.160 % Change From 1 Year High (%) -68.54
2 Years Range 1.271 - 19.200 Change From 2 Years Low +4.769 % Change From 2 Years Low (%) +375.10
Change From 2 Years High -13.160 % Change From 2 Years High (%) -68.54
5 Years Range 1.271 - 68.800 Change From 5 Years Low +4.769 % Change From 5 Years Low (%) +375.10
Change From 5 Years High -62.760 % Change From 5 Years High (%) -91.22
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Aug 2020 6.300 6.300 5.910 6.040 385,647 -
10 Aug 2020 6.350 6.440 6.200 6.290 305,088 -
07 Aug 2020 6.130 6.400 6.110 6.340 357,180 -
06 Aug 2020 6.230 6.260 6.150 6.160 169,534 -
05 Aug 2020 6.250 6.340 6.200 6.290 211,234 -
04 Aug 2020 6.260 6.369 6.120 6.240 287,052 -
03 Aug 2020 6.110 6.490 6.040 6.410 531,656 -
31 Jul 2020 6.120 6.340 6.080 6.240 319,497 -
30 Jul 2020 6.400 6.470 6.010 6.150 507,628 -
29 Jul 2020 6.060 6.875 5.900 6.560 1,642,238 -
28 Jul 2020 6.000 6.200 5.850 6.040 399,358 -
27 Jul 2020 6.350 6.350 5.780 6.090 886,439 -
24 Jul 2020 6.510 6.570 6.060 6.380 820,543 -
23 Jul 2020 6.720 6.835 6.460 6.640 1,262,684 -
22 Jul 2020 6.800 7.081 6.700 6.900 1,173,438 -
21 Jul 2020 7.000 7.180 6.830 6.960 978,838 -
20 Jul 2020 6.960 7.450 6.650 7.100 1,471,467 -
17 Jul 2020 7.090 7.130 6.700 6.940 914,060 -
16 Jul 2020 6.660 7.140 6.650 7.090 795,359 -
15 Jul 2020 6.880 7.040 6.550 6.910 663,034 -
14 Jul 2020 7.000 7.250 6.500 7.090 1,822,434 -
13 Jul 2020 7.720 7.850 7.310 7.410 800,224 -
Summary
Current 2 Weeks
(29 Jul 2020 to 11 Aug 2020)
6.060 6.875 5.900 6.040 4,716,754 -
Previous 2 Weeks
(15 Jul 2020 to 28 Jul 2020)
6.880 7.040 5.900 6.040 9,365,220 -
4 Weeks from
(16 Jun 2020 to 14 Jul 2020)
6.740 7.240 5.900 7.090 47,643,429 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.